Checkmate Pharmaceuticals Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 25
Employees
  • Stock Symbol
  • CMPI
Stock Symbol
  • Share Price
  • $6.67
  • (As of Friday Closing)

Checkmate Pharmaceuticals General Information

Description

Checkmate Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing its proprietary technology to harness the power of the immune system to combat cancer.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
NAS
Primary Office
  • 245 Main Street
  • 2nd Floor
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000

Checkmate Pharmaceuticals Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Checkmate Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.67 $7.06 $6.51 - $23.10 $153M 21.6M 49.3K -$4.49

Checkmate Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 177,082 177,082
Revenue 0 0
EBITDA (28,489) (20,994)
Net Income (28,292) (20,814)
Total Assets 5,126 12,494
Total Debt 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Checkmate Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Checkmate Pharmaceuticals‘s full profile, request access.

Request a free trial

Checkmate Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Checkmate Pharmaceuticals‘s full profile, request access.

Request a free trial

Checkmate Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Checkmate Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing its pr
Other Pharmaceuticals and Biotechnology
Cambridge, MA
25 As of 2020
00000
0000 0000-00-00
00000000 00000

000000 0

or incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation u
0000 000000000
Burlingame, CA
00 As of 0000
00000
0000 0000-00-00
00000000 00000

00000000

abore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nis
0000 000000000
Seattle, WA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Checkmate Pharmaceuticals Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Corvus Pharmaceuticals Formerly VC-backed Burlingame, CA 00 00000 00000000 00000
000000000000 Venture Capital-Backed Seattle, WA 00 00000 00000000000 00000
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
You’re viewing 5 of 23 competitors. Get the full list »

Checkmate Pharmaceuticals Executive Team (19)

Name Title Board Seat Contact Info
Barry Labinger Chief Executive Officer & Board Member
Robert Dolski Chief Financial Officer
Jonathan Lieber Chief Financial Officer, Finance
Karen Brennan Chief Operating Officer, Operations
Art Krieg MD Co-Founder, Chief Scientific Officer & Board Member
You’re viewing 5 of 19 executive team members. Get the full list »

Checkmate Pharmaceuticals Board Members (13)

Name Representing Role Since
Alan Fuhrman Self Board Member 000 0000
Art Krieg MD Checkmate Pharmaceuticals Co-Founder, Chief Scientific Officer & Board Member 000 0000
Barry Labinger Checkmate Pharmaceuticals Chief Executive Officer & Board Member 000 0000
Ben Auspitz F-Prime Capital Board Member 000 0000
Corey Goodman Ph.D venBio Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Checkmate Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Checkmate Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Checkmate Pharmaceuticals‘s full profile, request access.

Request a free trial